Oxaliplatin, gemcitabine, and erlotinib study in patients with advanced chemo-naive pancreatic cancer
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2014
At a glance
- Drugs Gemcitabine (Primary) ; Oxaliplatin (Primary) ; Erlotinib
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 19 Jan 2014 According to ClinicalTrials.gov record, Status changed from recruiting to discontinued.
- 27 Mar 2011 Planned End Date changed from 1 Jan 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 07 Apr 2008 New trial record.